Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07787689 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Intermittent vs Alternate Daily Regimen of Prednisolone in Ambulatory Boys With Duchenne Muscular Dystrophy

Name: Intermittent vs Alternate Daily Regimen of Prednisolone in Ambulatory Boys With Duchenne Muscular Dystrophy — clinical trial record (NCT07787689)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhaseNot applicable

SponsorMuhammad Aamir Latif

Started2026-09-15

View on ClinicalTrials.gov ↗

The alternate-day regimen is hypothesized to reduce hypothalamic-pituitary-adrenal (HPA) axis suppression and decrease steroid-related toxicity. Similarly, intermittent regimens aim to provide periodic steroid exposure sufficient for muscle preservation while allowing recovery periods to limit side effects. There is a critical need for localized, prospective data to determine which protocol offers the optimal balance of efficacy and safety for pediatric patients in Pakistan.

Trial Details

NCT Number	NCT07787689
Lead Sponsor	Muhammad Aamir Latif
Conditions	Duchenne Muscular Dystrophy
Enrollment	40 participants
Start Date	2026-09-15
Primary Completion	2027-03-15 (estimated)
Study Completion	2027-03-15 (estimated)
Updated on ClinicalTrials.gov	2026-08-26